English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
MoonGazer commented on a stock · Mar 16 21:18

Feel something coming

$Lexicon Pharmaceuticals (LXRX.US)$ Lexicon Pharmaceuticals (LXRX)
...
Currently, the analyst consensus on Lexicon Pharmaceuticals is a Moderate Buy with an average price target of $3.67, representing a 919.4% upside. In a report issued on March 3, Needham also maintained a Hold rating on the stock.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
6317 Views
Comment
Sign in to post a comment
    avatar
    MoonGazer
    One trade at a time...
    175
    Followers
    18
    Following
    1278
    Visitors
    Follow

    Market Insights

    Inverse ETF Inverse ETF
    No. Symbol Turnover
    Sample Name
    Sample Code
     3.54B
    Sample Name
    Sample Code
     1.38B
    Sample Name
    Sample Code
     928.55M
    4
    Direxion Daily S&P 500 Bear 3X Shares ETF
    SPXS
    532.16M
    5
    T-Rex 2x Inverse Tesla Daily Target ETF
    TSLZ
    398.48M
    Unlock Now

    Discussing

    2025 Buffett shareholders' meeting: What's the new buzz in value investing?
    🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
    Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs

    Monetary Policy: Navigating the Fed's Rate Cut Cycle

    Changing Fed policy is altering the market math for investors.

    Reassessing Chinese Assets

    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

    - No more -